Rochester Regional Health

Rochester, New York 14626

2 studies enrolling now · 11 studies all time

What they study most

Allergic Reaction, Aortic Valve Failure, Asthma, Aspirin-Induced, CKD Stage 3, COVID-19, Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure, Degenerative Disc Disease, Heart Failure With Preserved Ejection Fraction, Mast Cell Disorder, Metastatic Pancreas Adenocarcinoma, Mitral Valve Regurgitation

Studies at this site

• Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System — Recruiting now
• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• MitraClip REPAIR MR Study — Running, not enrolling
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial — Completed
• SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke — Completed
• COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations — Completed
• Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation — Completed
• Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) — Completed
• Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain — Completed
• Radiofrequency (RF) Ablation for Atrial Fibrillation (AF) in Patients With Heart Failure With Preserved Ejection Fraction — Stopped early